ConductScience.org, home

Paper36922828

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.

Celichowski P and 10 others. J Transl Med, 2023. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. Papers, record 36922828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36922828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.
PubMed
Journal
J Transl Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
3.51
iCite
Revised in PubMed
2023-09-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Celichowski PPiotr
2Turi MMarcello
3Charvátová SSandra
4Radhakrishnan DDhwani
5Feizi NNeda
6Chyra ZZuzana
7Šimíček MMichal
8Jelínek TTomáš
9Bago JRJuli Rodriguez
10Hájek RRoman
11Hrdinka MMatoušhttps://orcid.org/0000-0002-2981-2825

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, Chimeric AntigenMajor topic
NeoplasmsMajor topic
Humans
Immunotherapy, Adoptive
T-Lymphocytes
Immunotherapy
Receptors, Antigen, T-Cell

Source PubMed

Download CSV of topics

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134778803NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.Blood Cancer Discov2021https://conductscience.org/library/papers/34778803PubMed
232191035Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor.J Am Chem Soc2020https://conductscience.org/library/papers/32191035PubMed
323032741Redirecting gene-modified T cells toward various cancer types using tagged antibodies.Clin Cancer Res2012https://conductscience.org/library/papers/23032741PubMed
423352111Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.J Autoimmun2013https://conductscience.org/library/papers/23352111PubMed
532215059Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release.Ther Adv Med Oncol2020https://conductscience.org/library/papers/32215059PubMed
627329987A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration.Cancer Immunol Res2016https://conductscience.org/library/papers/27329987PubMed
730889382Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.Cancer Cell2019https://conductscience.org/library/papers/30889382PubMed
831429760Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.Mol Cancer2019https://conductscience.org/library/papers/31429760PubMed
931900462'Off-the-shelf' allogeneic CAR T cells: development and challenges.Nat Rev Drug Discov2020https://conductscience.org/library/papers/31900462PubMed
1024358223Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma.PLoS One2013https://conductscience.org/library/papers/24358223PubMed
1134697491Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety.Nat Nanotechnol2021https://conductscience.org/library/papers/34697491PubMed
1234216875Emerging mammalian gene switches for controlling implantable cell therapies.Curr Opin Chem Biol2021https://conductscience.org/library/papers/34216875PubMed
1323839099TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.Mol Ther Nucleic Acids2013https://conductscience.org/library/papers/23839099PubMed
1435158839Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers.Cancers (Basel)2022https://conductscience.org/library/papers/35158839PubMed
1510724039Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies.Hum Gene Ther2000https://conductscience.org/library/papers/10724039PubMed
1633113407Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator.Cell Chem Biol2021https://conductscience.org/library/papers/33113407PubMed
1730046161TanCAR T cells targeting CD19 and CD133 efficiently eliminate MLL leukemic cells.Leukemia2018https://conductscience.org/library/papers/30046161PubMed
1834801727Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor.Mol Ther2022https://conductscience.org/library/papers/34801727PubMed
1935146940Light-Controllable Binary Switch Activation of CAR T Cells.ChemMedChem2022https://conductscience.org/library/papers/35146940PubMed
2031272471Engineering switchable and programmable universal CARs for CAR T therapy.J Hematol Oncol2019https://conductscience.org/library/papers/31272471PubMed

See all 207 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42824951Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.BMJ Neurol Open2026https://conductscience.org/library/papers/42824951PubMed
42079032Hypoxic tumor microenvironment and immune cell dynamics: From metabolic reprogramming to therapeutic innovation.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42079032PubMed
41963304Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41963304PubMed
41800026From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy.Immune Netw2026https://conductscience.org/library/papers/41800026PubMed
41737839Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors.Small Sci2026https://conductscience.org/library/papers/41737839PubMed
41586404Optogenetic engineering of synthetic and natural receptors: design principles, functional mechanisms and biomedical applications.Regen Biomater2026https://conductscience.org/library/papers/41586404PubMed
41454396Immune effector cell-associated neurotoxicity syndrome following CAR T-cell therapy: a review of recent advances.J Transl Med2025https://conductscience.org/library/papers/41454396PubMed
41369346Strategies for the Development of NK Cell-Based Therapies for Cancer Treatment.Cells2025https://conductscience.org/library/papers/41369346PubMed
41162648Small-molecule control of CAR T cells.Nat Rev Chem2025https://conductscience.org/library/papers/41162648PubMed
40855662From Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40855662PubMed
40821776Dual targeting of BCMA and SLAMF7 with the CARtein system: chimeric antigen receptors with intein-mediated splicing elicit specific T cell activation against multiple myeloma.Front Immunol2025https://conductscience.org/library/papers/40821776PubMed
40699780The Struggle Between Chimeric Antigen Receptor T-Cell Therapy and Neurological Complications in Acute Lymphoblastic Leukemia Treatment.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699780PubMed
40646591Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.Cancer Cell Int2025https://conductscience.org/library/papers/40646591PubMed
40624498Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.Mol Cancer2025https://conductscience.org/library/papers/40624498PubMed
40597436Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.Biomark Res2025https://conductscience.org/library/papers/40597436PubMed
40182067A High-Throughput, Three-Dimensional Multiple Myeloma Model Recapitulating Tumor-Stroma Interactions for CAR-Immune Cell-Mediated Cytotoxicity Assay.Immunotargets Ther2025https://conductscience.org/library/papers/40182067PubMed
39901030Novel strategies to manage CAR-T cell toxicity.Nat Rev Drug Discov2025https://conductscience.org/library/papers/39901030PubMed
39697333From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.Front Immunol2024https://conductscience.org/library/papers/39697333PubMed
39417449CAR-T therapy for gastrointestinal cancers: current status, challenges, and future directions.Braz J Med Biol Res2024https://conductscience.org/library/papers/39417449PubMed
39328262Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.J Extracell Biol2024https://conductscience.org/library/papers/39328262PubMed

See all 30 cited byDownload CSV of cited by

Genes68

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALPG251PubTator's text mininghttps://conductscience.org/library/genes/251NCBI Gene
ASRGL180150PubTator's text mininghttps://conductscience.org/library/genes/80150NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BRD423476PubTator's text mininghttps://conductscience.org/library/genes/23476NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD9322918PubTator's text mininghttps://conductscience.org/library/genes/22918NCBI Gene
CIB110519PubTator's text mininghttps://conductscience.org/library/genes/10519NCBI Gene
CRBN51185PubTator's text mininghttps://conductscience.org/library/genes/51185NCBI Gene
CRY21408PubTator's text mininghttps://conductscience.org/library/genes/1408NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene

See all 68 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36922828

GET https://conductscience.org/api/papers/v1/36922828/references?page=2